Global  

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 The move comes after a report linked the drug to an increased fatality rate among those with coronavirus.

The study in medical journal 'The Lancet' adds that it can increase odds of heart failure in coronavirus patients.

The decision has been confirmed by World Health Organization director-general Tedros Adhanom Ghebreyesus.

Tedros Adhanom Ghebreyesus WHO chief scientist Soumya Swaminathan adds that more research on hydroxychloroquine is needed.

Soumya Swaminathan Further trials conducted in the U.S. and France claim hydroxychloroquine won't help battle the pandemic.

Hydroxychloroquine can help treat malaria and lupus, but its effectiveness against COVID-19 remains unknown.

President Donald Trump has often claimed that hydroxychloroquine is useful against the coronavirus.

Trump even recently said that he was personally taking the drug as a precaution.


You Might Like

Related news from verified sources

WHO stops trials, but ICMR says HCQ can be used as preventive drug

A day after the WHO suspended testing of hydroxychloroquine for Covid-19 patients, the Indian Council...
IndiaTimes - Published


Tweets about this


Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine [Video]

US Hospitals Cut Back On Use Of Hydroxychloroquine

President Donald Trump promoted hydroxychloroquine, a malaria drug, as a COVID-19 treatment. According to Reuters, several studies suggest the drug isn’t effective against COVID-19 and creates..

Credit: Wochit Entertainment     Duration: 00:32Published
Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct [Video]

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early..

Credit: HT Digital Content     Duration: 03:14Published
WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG [Video]

WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early..

Credit: ANI     Duration: 01:36Published